Efficacy and safety of Vitamin C vaginal tablets in the treatment of non-specific vaginitis: A randomised, double blind, placebo-controlled study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 117, Issue 1, 2004, Pages 70-75

  Petersen, E Eiko ^a   Magnani, Paola ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Polichem SA   (Switzerland)

Author keywords

Ascorbic acid; Bacterial vaginosis; Non specific vaginitis; Vitamin C

Indexed keywords

ASCORBIC ACID; PLACEBO;

ACIDITY; ADULT; ANAMNESIS; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CLUSTER ANALYSIS; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EVALUATION; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMED CONSENT; LACTOBACILLUS; MICROSCOPY; ODOR; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SYMPTOM; TABLET; VAGINA DISCHARGE; VAGINA SMEAR; VAGINITIS;

EID: 5044232355     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.02.032     Document Type: Article

References (14)

1. Georgijevic A., Cjukic-Ivancevic S., Bujko M. Bacterial vaginosis. Epidemiology and risk factors. Srp. Arh. Celok. Lek. 128(1-2):2000;29-33
2. Gonzales Pedraza Aviles A., Ortiz Zaragoza M.C., Irigoyen Coria A. Bacterial vaginosis: a broad overview. Rev. Latinoam. Microbiol. 41(1):1999;25-34
3. Hillier SL, Holmes KK. Bacterial vaginosis. In: Holmes KK, Mardh PA, Sparling PF, et al, editors. Sexually transmitted diseases. New York: McGraw Hill Information Services Co., 1990, p. 547-59.
4. Jacobsson B., Pernevi P., Chidekel L., Jorgen Platz-Christensen J. Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis. Acta Obstet. Gynecol. Scand. 81(11):2002;1006-1010
5. Romero R., Espinoza J., Chaiworapongsa T., Kalache K. Infection and prematurity and the role of preventive strategies. Semin. Neonatol. 7(4):2002;259-274
6. Hillier SL, Nugent RP, Eschenbach DA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The vaginal infections and prematurity study group. N Engl J Med 1995;333(26):1737-42.
7. Holst E., Goffeng A.R., Andersch B. Bacterial vaginosis and vaginal micoorganisms in idiopathic premature labor and association with pregnancy outcome. J. Clin. Microbiol. 32(1):1994;176-186
8. Krohn M.A., Hillier S.L., Lee M.L., Rabe L.K., Eschenbach D.A. Vaginal bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J. Inf. Dis. 164:1991;88-93
9. Watts D.H., Kroh M.A., Hillier S.L., Eschenbach D.A. Bacterial vaginosis as a risk-factor for post-cesarean endometritis. Obstet. Gynecol. 75(1):1990;52-58
10. Wang J. Bacterial vaginosis. Prim. Care Update Obstet. Gynecol. 7(5):2000;181-185
11. SOGC Committee Opinion. Bacterial vaginosis. SOGC Clinical Practice Guidelines No. 14, March 1997.
12. Saling E., Schreiber M., al-Taie T. A simple, efficient and inexpensive program for preventing prematurity. J. Perinat. Med. 29(3):2001;199-211
13. Petersen E.E. Der Einsatz von Vitamin C (Vagi-C) zur normalisierung der vaginalflora. Gyne. 19:1998;1-3
14. Petersen E.E. Prophylaxe durch intravaginale applikation von L-Askorbinsäure. Gyne. 20:1999;1-4